Lantheus (NASDAQ:LNTH) Hits New 1-Year Low - Should You Sell?

Key Points

• Lantheus Holdings shares hit a new 52-week low at $49.58, down from a previous close of $72.63, marking a significant decline of 31.1%.
• Despite the drop in share price, analysts maintain a mostly positive outlook with six buy ratings and an average price target of $131.20.
• Insider trading activity showed that Director Mary Anne Heino sold 26,066 shares at an average price of $76.83, reducing her stake by 7.56%.

Lantheus Holdings, Inc. (NASDAQ:LNTH - Get Free Report) shares reached a new 52-week low on Wednesday . The company traded as low as $50.85 and last traded at $49.58, with a volume of 351158 shares traded. The stock had previously closed at $72.63.

Wall Street Analysts Forecast Growth

LNTH has been the topic of a number of research reports. William Blair reissued a "market perform" rating on shares of Lantheus in a report on Wednesday, July 16th. Truist Financial lowered their target price on shares of Lantheus from $127.00 to $117.00 and set a "buy" rating for the company in a report on Thursday, May 8th. Wall Street Zen upgraded shares of Lantheus from a "hold" rating to a "buy" rating in a report on Thursday, May 8th. Finally, B. Riley decreased their price objective on shares of Lantheus from $122.00 to $109.00 and set a "buy" rating for the company in a report on Monday, June 23rd. One analyst has rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $131.20.

Lantheus Stock Down 31.1%

The company has a current ratio of 5.74, a quick ratio of 5.46 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $3.46 billion, a P/E ratio of 14.22 and a beta of 0.14. The company's fifty day simple moving average is $77.54 and its 200 day simple moving average is $87.67.

Lantheus (NASDAQ:LNTH - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The medical equipment provider reported $1.53 EPS for the quarter, missing the consensus estimate of $1.64 by ($0.11). Lantheus had a net margin of 16.55% and a return on equity of 36.99%. The firm had revenue of $372.76 million for the quarter, compared to analysts' expectations of $377.37 million. During the same period last year, the company posted $1.69 earnings per share. The business's revenue for the quarter was up .8% compared to the same quarter last year. Research analysts expect that Lantheus Holdings, Inc. will post 6.01 EPS for the current year.

Insider Activity

In other news, Director Mary Anne Heino sold 26,066 shares of the firm's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $76.83, for a total transaction of $2,002,650.78. Following the sale, the director owned 318,650 shares of the company's stock, valued at $24,481,879.50. This trade represents a 7.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.00% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Lantheus

A number of institutional investors and hedge funds have recently made changes to their positions in the business. State of Michigan Retirement System boosted its holdings in shares of Lantheus by 0.6% in the first quarter. State of Michigan Retirement System now owns 16,600 shares of the medical equipment provider's stock worth $1,620,000 after buying an additional 100 shares during the last quarter. Signaturefd LLC raised its stake in Lantheus by 36.5% during the 1st quarter. Signaturefd LLC now owns 434 shares of the medical equipment provider's stock worth $42,000 after acquiring an additional 116 shares during the period. Intrust Bank NA raised its stake in Lantheus by 2.9% during the 1st quarter. Intrust Bank NA now owns 4,417 shares of the medical equipment provider's stock worth $431,000 after acquiring an additional 125 shares during the period. Focus Financial Network Inc. raised its stake in Lantheus by 4.0% during the 2nd quarter. Focus Financial Network Inc. now owns 3,576 shares of the medical equipment provider's stock worth $293,000 after acquiring an additional 136 shares during the period. Finally, Nisa Investment Advisors LLC raised its stake in Lantheus by 2.1% during the 1st quarter. Nisa Investment Advisors LLC now owns 6,691 shares of the medical equipment provider's stock worth $653,000 after acquiring an additional 139 shares during the period. Hedge funds and other institutional investors own 99.06% of the company's stock.

About Lantheus

Lantheus Holdings, Inc develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.